Renata PLC (DSE:RENATA)
Bangladesh · Delayed Price · Currency is BDT 414.70
-0.50 (-0.12%)
At close: May 6, 2026
Renata Market Cap
Renata has a market cap or net worth of 47.62 billion as of May 6, 2026. Its market cap has decreased by -17.64% in one year.
Market Cap
47.62B
Enterprise Value
65.59B
Revenue
44.93B
Ranking
n/a
PE Ratio
17.44
Stock Price
414.70
Market Cap Chart
Since June 2, 2003, Renata's market cap has increased from 320.77M to 47.62B, an increase of 14,746.07%. That is a compound annual growth rate of 24.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 47.56B | 5.84% |
| Dec 30, 2025 | 44.94B | -38.31% |
| Dec 30, 2024 | 72.84B | -47.85% |
| Dec 27, 2023 | 139.69B | - |
| Dec 29, 2022 | 139.69B | -0.67% |
| Dec 30, 2021 | 140.64B | 30.38% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Square Pharmaceuticals PLC. | 186.95B |
| Beximco Pharmaceuticals PLC. | 52.20B |
| Unilever Consumer Care | 39.89B |
| Beacon Pharmaceuticals | 23.70B |
| The ACME Laboratories | 16.04B |
| Asiatic Laboratories | 13.18B |
| The IBN SINA Pharmaceutical Industry | 9.62B |
| Navana Pharmaceuticals | 6.35B |